PCI 7 November 2023, 15:22
Thermofisher: Thu 29 February 2024, 11:15
BMG Labtech: Wed 18 September 2024, 11:55
Owen Mumford 12 January 2022, 16:46

Current Edition

Cell and Gene Therapy

Upcoming Events

PEGS Boston – 17/02/2025
NextGen BioMed – 04/02/2025
BioTrinity 2025 – January 30th 2025
Elrig R&I 2025 – 27th January 2025
Biotechnology Show 2025: 20th January 2025
Anglonordic: 16th January 2025
AI in Drug Discovery – SAE media – January 14th 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault: Wed 17 July 2024, 11:46
Aurisco – 04/02/2025

Biopharmaceuticals Market Strongly guided by Companies like ABBVIE, AMGEN, BRISTOL

The market is expected to register a CAGR of 8.5% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological advancements.

Increasing acceptance for biopharmaceuticals and huge market demand

Opportunities in biopharmaceuticals have been increasing over the past decade. The efficacy and the safety of the drugs are some of the key products features that drive the market growth. There have been biopharmaceutical products that are improving the quality of life and reducing the death rates in patients with HIV/AIDs, Cancer, Cystic fibrosis, rheumatoid arthritis. Biopharmaceuticals have reduced the number of deaths caused due to cancer and HIV/AIDS in the last decade. The efficacy of the drugs and the safety has increased the acceptance for biopharmaceuticals.

High-end manufacturing requirements

Unlike conventional pharmaceuticals, biopharmaceuticals are manufactured using living biological systems. Due to this, the biopharmaceutical manufacturing requires specialized equipment and devices like incubators that can support these biological systems. The cost of these devices and equipment is high as compared to regular manufacturing equipment. Along with this, most of the biopharmaceuticals require custom built manufacturing equipment and highly specialized personnel to operate them. Due to these high-end manufacturing requirements, the resources and time required to setup a biopharmaceutical manufacturing facility is very high which makes scaling really tough. So, these factors are acting as a restraint for Biopharmaceuticals market.

North America to Dominate the Market

The Biopharmaceuticals market is segmented by type of treatment and geography. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.

North America dominates the Biopharmaceuticals market due to the increasing technological advancements and high investment & funding to support development of Biopharmaceuticals. Asia-Pacific is also expected to propel the Biopharmaceuticals market owing to factors, such as increasing accessibility to healthcare facilities in the region, and increasing economic growth.

Key developments in the market

In January, 2018, GE Healthcare’s Flex Factory single-use bio manufacturing platform has been selected by Clover Biopharmaceuticals, a Chinese developer of biologics, for its new facility located in Changxing, Zhejiang.

In January, 2018, Sandoz, a Novartis division and the global leader in biosimilars, announced a global partnership with Asia’s premier biopharmaceuticals company, Biocon, to develop, manufacture and commercialize multiple biosimilars in immunology and oncology for patients worldwide.

Major key players: ABBVIE, AMGEN, BRISTOL – MYERS SQUIBB, ELI LILY & CO, JOHNSON & JOHNSON, MERCK & CO. INC, GLAXOSMITHKLINE PLC, ROCHE, PFIZER and NOVARTIS AG etc.

Newcells 3 June 2024, 15:12
Novonordisk: Wed 17 July 2024, 11:22
FujiFilm 30 October 2023, 16:23
Autoscribe Mon 26 June 2023, 15:15
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
GenXPro: Mon 16 September 2024, 10:40